Wuxi Pharmatech Enters Into Definitive Merger Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
William Blair Downgrades WuXi PharmaTech (WX) to Market Perform
August 17, 2015 7:36 AM EDTWilliam Blair downgraded WuXi PharmaTech (NYSE: WX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on WuXi PharmaTech click here. For more ratings news on WuXi PharmaTech click here.
Shares of WuXi PharmaTech closed at $43.86 yesterday.
... MoreWuXi PharmaTech (WX) Enters $46/ADS Merger Agreement
August 14, 2015 6:36 AM EDTWuXi PharmaTech (NYSE: WX) announced that it has entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") with New WuXi Life Science Limited ("Parent") and WuXi Merger Limited ("Merger Sub"), a wholly owned subsidiary of Parent.
Pursuant to the Merger Agreement, Parent will acquire the Company for cash consideration equal to US$5.75 per ordinary share of the Company (each, a "Share") and US$46 per American Depositary Share of the Company, each representing eight Shares (each, an "ADS"), or approximately US$3.3 billion in aggregate cash consideration. This represents a 16.5%... More
